Fertility Add-Ons the Evidence Doesn't Support

What counts as an IVF add-on — and the problem with most of them

An IVF add-on is an optional procedure, test, or treatment sold on top of a standard IVF cycle, usually at extra cost and usually marketed as a way to improve your chances. The problem is that many of the best-known add-ons are not supported by good evidence that they raise the odds of a baby, and a handful may even cause harm.

The UK's fertility regulator reviewed the common add-ons and rated them, concluding that most lack good evidence of benefit and some may be harmful 1Ref 1Human Fertilisation and Embryology Authority (2024).Treatment add-ons with limited evidence.That the UK regulator rates common IVF add-ons on a five-tier color-coded scale, that most lack good evidence of benefit and some may be harmful, and that a standard cycle without add-ons is often the better value.. The extras it rates include preimplantation genetic testing, assisted hatching, the endometrial scratch, and time-lapse imaging 1Ref 1Human Fertilisation and Embryology Authority (2024).Treatment add-ons with limited evidence.That the UK regulator rates common IVF add-ons on a five-tier color-coded scale, that most lack good evidence of benefit and some may be harmful, and that a standard cycle without add-ons is often the better value.. One nuance matters throughout: unproven for routine use is not the same as useless for everyone — a few add-ons have a real role for specific patients, and this page is not an argument that all of them are worthless. It is an argument that the marketing tends to outrun the evidence, and that the gap between the pitch and the proof is yours to check before you pay. An add-on being sold does not mean it has been shown to work.

The add-ons you're most likely to be offered

Most clinics offer a fairly standard menu of extras, and knowing the names in advance takes the pressure off the moment they are proposed. How each one is supposed to help — and whether it does — is its own subject; the goal here is only to recognize the menu and know that a published evidence rating already exists for every item on it.

The common add-ons a clinic may suggest include genetic screening of embryos, an extra sperm-injection step, assisted hatching to thin the shell around an embryo, an endometrial scratch meant to prime the lining, and time-lapse imaging that films the embryos as they grow 1Ref 1Human Fertilisation and Embryology Authority (2024).Treatment add-ons with limited evidence.That the UK regulator rates common IVF add-ons on a five-tier color-coded scale, that most lack good evidence of benefit and some may be harmful, and that a standard cycle without add-ons is often the better value.. Some clinics also offer immune treatments or supplement regimens framed as boosting implantation. Nearly all of these sit in the unproven range of the regulator's ratings, and a standard cycle without any of them is often the better value 1Ref 1Human Fertilisation and Embryology Authority (2024).Treatment add-ons with limited evidence.That the UK regulator rates common IVF add-ons on a five-tier color-coded scale, that most lack good evidence of benefit and some may be harmful, and that a standard cycle without add-ons is often the better value.. The point is not to memorize a verdict for each item, but to treat every one as a claim that has to earn its place on your bill — and to know exactly where to look the claim up.

How the evidence gets graded, and why a color code helps

You do not have to read the trials yourself to judge an add-on. The UK regulator publishes a five-tier, color-coded rating for the common IVF extras, summarizing whether the evidence shows a benefit, shows no benefit, or is simply too thin to tell. Learning to read that scale is most of the skill, and it travels well even outside the UK, because the underlying studies are the same ones your own clinic is weighing.

The hfea traffic-light ratings place each add-on on a scale from evidence of benefit down to possibly harmful, and most sit in the unproven middle 1Ref 1Human Fertilisation and Embryology Authority (2024).Treatment add-ons with limited evidence.That the UK regulator rates common IVF add-ons on a five-tier color-coded scale, that most lack good evidence of benefit and some may be harmful, and that a standard cycle without add-ons is often the better value.. The same regulator's plain verdict is that a standard cycle without add-ons is often the better value 1Ref 1Human Fertilisation and Embryology Authority (2024).Treatment add-ons with limited evidence.That the UK regulator rates common IVF add-ons on a five-tier color-coded scale, that most lack good evidence of benefit and some may be harmful, and that a standard cycle without add-ons is often the better value.. When a clinic offers an extra, the HFEA add-on ratings tell you where the burden of proof currently stands — green means the evidence supports it, and the colors below it mean the case has not yet been made. That single lookup reframes a sales pitch as a claim you are allowed to check, and it turns the conversation from 'do you want the best possible chance?' into 'what does the rating say, and does it apply to me?'

Unproven is not the same as disproven

A fair reading of the evidence has three buckets, not two, and confusing them is how careful people end up overpaying. An add-on can be shown to help, shown not to help, or simply not yet studied well enough for anyone to know. Most of the marketed extras live in that third bucket, and it is a genuinely different situation from either of the other two.

An add-on in the 'not enough evidence' zone is not necessarily a fraud — it is a gamble. The honest framing is that you would be paying to take part in an experiment, but without the safeguards, the free treatment, or the shared learning that a real clinical trial provides 1Ref 1Human Fertilisation and Embryology Authority (2024).Treatment add-ons with limited evidence.That the UK regulator rates common IVF add-ons on a five-tier color-coded scale, that most lack good evidence of benefit and some may be harmful, and that a standard cycle without add-ons is often the better value.. That does not make trying one irrational for every person, but it does make it a decision that deserves informed consent, a clear price, and the humility that the benefit may turn out to be zero. When a clinic presents an unproven add-on as though it were established, it has quietly moved an item from the third bucket into the first without the evidence to justify the move. Learning to notice that shift is most of what protects you.

PGT-A: the flagship add-on the trials didn't back

Preimplantation genetic testing for aneuploidy — genetic screening of embryos for the correct number of chromosomes — is the clearest example of an add-on whose marketing outran its evidence. It is often presented as a way to raise IVF success for everyone, and the logic sounds airtight: test the embryos, transfer only the ones with the right chromosome count, and do better. The trials did not bear that out for the general population.

The current professional position is that the value of PGT-A as a routine screen for all IVF patients has not been demonstrated, and recent multicenter randomized trials found similar overall pregnancy outcomes with and without it 2Ref 2Practice Committees of ASRM and SART (2024).The use of preimplantation genetic testing for aneuploidy: a committee opinion.That the value of PGT-A as a routine screen for all IVF patients has not been demonstrated, and recent multicenter RCTs found similar overall pregnancy outcomes with and without it.. There are reasons it can fall short — a biopsy samples only a few cells, testing can misclassify an embryo that would have become a healthy baby, and the procedure is not free of risk — but the mechanics of when it might genuinely help belong to their own article. The contrast worth holding onto is this: the single change that most reliably improves safety costs nothing extra and is not an add-on at all. Transferring one good embryo rather than several reduces multiple-birth risk while preserving cumulative live-birth rates 3Ref 3Practice Committees of ASRM and SART (2021).Guidance on the limits to the number of embryos to transfer: a committee opinion.That elective single-embryo transfer reduces multiple-birth risk while preserving cumulative live-birth rates — the evidence-based, no-extra-cost practice that outperforms paid add-ons on safety.. So the honest point is narrower and firmer: a routine PGT-A upsell offered to every patient is not evidence-based, however confidently it is pitched.

ICSI for everyone: an upgrade with a narrow real indication

ICSI — injecting a single sperm directly into each egg — is essential for some couples and unnecessary for many. It was developed to overcome male-factor infertility, but it is frequently sold as a routine upgrade to every IVF patient, which the evidence does not support. The ASRM ICSI indications are specific, not universal, and the difference is easy to lose in the momentum of a consultation.

The professional guidance is direct: absent male-factor infertility or a prior fertilization failure, routine ICSI on all eggs does not improve live-birth rates 4Ref 4Practice Committees of ASRM and SART (2026).Intracytoplasmic sperm injection for nonmale factor indications: a committee opinion.That absent male-factor infertility or prior fertilization failure, routine ICSI on all oocytes does not improve live-birth rates — so ICSI is justified by a specific indication rather than offered as a default upgrade.. So the honest answer to 'do i need icsi with ivf' depends entirely on whether you have the indication. If your semen analysis is normal and you have no history of failed fertilization, it is an add-on you can often decline — and the difference is not subtle, on the bill or in the lab. Because ICSI has become the default at many clinics rather than a considered choice, it is worth asking specifically why it is being recommended for you, and what your team would expect to happen without it.

Why unproven add-ons keep selling

If the evidence is weak, why are add-ons everywhere? Three forces keep them on the menu: hope, money, and conflict of interest. People facing long odds will reasonably try almost anything; clinics earn margin on extras; and the same clinic that recommends an add-on is often the one that sells it, which is a structural conflict rather than a character flaw.

Fertility care is already expensive and paid largely out of pocket, with costs rising steeply toward IVF 6Ref 6Katz P, Showstack J, Smith JF, et al. (2011).Costs of infertility treatment: results from an 18-month prospective cohort study.That infertility care is expensive and paid largely out of pocket, with costs rising steeply toward IVF — so every add-on lands on an already-heavy self-paid bill., so every add-on lands on a bill that is already heavy. Financial packages sharpen the tension. Refund and risk-sharing programs can carry conflicts of interest that push higher-risk or higher-cost care, which is exactly why ethics guidance insists success be defined in advance and every cost and exclusion be disclosed 5Ref 5Ethics Committee of ASRM (2023).Financial "risk-sharing" or refund programs in assisted reproduction: an Ethics Committee opinion.That risk-sharing and refund programs can carry conflicts of interest that push higher-risk care, and that ethics guidance requires success to be defined in advance and all costs and exclusions disclosed.. Seeing the ivf all-in cost — the base fee plus the stack of extras — makes the pressure visible in a way a single line item never does. None of this assumes bad faith; it means incentives exist, and you are allowed to account for them when you decide what to buy.

How to vet an add-on before you pay for it

Vetting an add-on comes down to a few blunt questions and one habit: make the clinic show the evidence for someone like you, not for patients in general. The most heavily marketed extras tend to target people after repeated disappointment, when hope is highest and judgment hardest — which is exactly when the questions matter most.

• Ask for the rating. Where does this add-on sit on the HFEA add-on ratings, and what does that color mean for the strength of the evidence?
• Ask whether it applies to you. A benefit shown in one narrow group is not a benefit for you; a normal test result can make an add-on pointless.
• Ask what it costs, and what declining it changes. If skipping it does not change the plan, that is worth knowing before you pay.
• Ask about harm, not only benefit. Some add-ons carry their own procedural risk, and a few may lower success rather than raise it 1Ref 1Human Fertilisation and Embryology Authority (2024).Treatment add-ons with limited evidence.That the UK regulator rates common IVF add-ons on a five-tier color-coded scale, that most lack good evidence of benefit and some may be harmful, and that a standard cycle without add-ons is often the better value. — 'might not help' and 'might hurt' are very different answers.
• Watch the behavior. A clinic that presents an unproven extra as necessary, or reaches for one right after a setback, is showing you a fertility clinic red flag — and vetting add-ons this way protects both your money and your odds.

Often the higher-value spend is not another extra at all. After repeated disappointment — recurrent implantation failure, when good embryos keep not implanting, or pregnancy loss — a thorough evaluation such as a complete female fertility workup, or a recurrent loss workup, tends to change management more than any add-on. The question is never 'is this add-on real?' but 'has it been shown to help someone in my situation?'